Clinical Trial Update: Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of repeated super-selective intraarterial bevacizumab plus carboplatin for relapsed/refractory glioblastoma multiforme and anaplastic astrocyt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma Multiforme

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Northwell Health | Conditions: Glioblastoma Multiforme, Anaplastic Astrocytoma | Phase 1, Phase 2 | Status: SUSPENDED